Alseroxylon

CHEMBL1201454 Phase 4 ได้รับการอนุมัติ Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
281.8 g/mol
LogP
Phase
4

A purified alkaloid fraction from Rauwolfia serpentina plants that depletes catecholamines from nerve endings, lowering blood pressure and heart rate, historically used in hypertension treatment. Like other rauwolfia alkaloids including reserpine, it has largely been replaced by newer antihypertensives with better side effect profiles.

น้ำหนักโมเลกุล

281.8300 g/mol

TPSA

101.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1C(O1)CCl.C(CNCCNCCNCCN)N

InChI

InChI=1S/C8H23N5.C3H5ClO/c9-1-3-11-5-7-13-8-6-12-4-2-10;4-1-3-2-5-3/h11-13H,1-10H2;3H,1-2H2

Molecular Formula

C11H28ClN5O

HBD / HBA

5 / 6

พันธะที่หมุนได้

11

อะตอมหนัก

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A purified alkaloid fraction from Rauwolfia serpentina plants that depletes catecholamines from nerve endings, lowering blood pressure and heart rate, historically used in hypertension treatment. Like other rauwolfia alkaloids including reserpine, it has largely been replaced by newer antihypertensives with better side effect profiles.

Yes, Alseroxylon is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201454. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 62816. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.